Is Aphria stock a good investment?
Real time Aphria Inc. (APHA) stock price quote, stock graph, news & analysis.
Should you invest in Aphria stock or not?
May 20, 2021 · APHA Aphria Inc. — Stock Price and Discussion | Stocktwits. Aphria Inc. NYSE Updated May 20, 2021 4:00 AM. APHA 15.38 0.07 (0.45%) Post-Market 0.11 (0.72%) 44,709. …
Should Aphria stock investors take the money and run?
Apr 11, 2022 · Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands.
Is Aphria a buy now?
Apr 03, 2022 · Aphria's stock was trading at C$3.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APHA stock has increased by 349.7% and is now trading at C$16.55.
Is Aphria a good stock to buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.Mar 11, 2021
Is Aphria a good long-term stock?
Because Aphria is relatively undervalued, the long-term return of its stock is likely to be higher than its business growth, which averaged 125.7% over the past three years and is estimated to grow 26.56% annually over the next three to five years.Mar 28, 2021
Is Aphria a buy or sell?
Currently, Aphria is a Zacks Rank #5 (Strong Sell) in the Medical - Products industry that ranks in the Bottom 41% of our Zacks Industry Rank.Apr 12, 2021
Will Aphria stock become Tilray?
After Tilray's (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction.May 3, 2021
Should I sell my Aphria stock?
Aphria Inc(APHA-T) Rating A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
What happens if I own Aphria stock?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
Should I hold Aphria?
The consensus among Wall Street analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
Is Aphria stock delisted?
Rivals Canopy Growth Corp and Aphria Inc also moved their U.S. listings to the Nasdaq in 2020, citing lower costs. Aphria delisted this year after its reverse merger with Nasdaq-listed Tilray . Aurora's shares will start trading on the Nasdaq on May 25 under the ticker symbol “ACB.”May 13, 2021
Why is Aphria stock dropping?
Aphria stock plunged Monday after the Canadian cannabis firm missed expectations for third-quarter sales and its net loss widened. Also falling were shares of Canadian peer Tilray , which plans to merge with Aphria.Apr 12, 2021
What happens to my Aphria stock when they merge with Tilray?
In December, Aphria (ticker: APHA) and Tilray (TLRY) announced a plan to merge the two businesses. Aphria would effectively conduct a reverse takeover of Tilray, taking its corporate name and its listing on the Nasdaq, with a 62% interest in the combined company.Apr 16, 2021
Is Tilray in the US?
Tilray Brands, Inc. (NASDAQ:TLRY) is one of the biggest Canadian cannabis companies that has been ramping up its presence in the US.Feb 11, 2022
What brands does Aphria own?
Aphria offers multiple products under a portfolio of recreational cannabis brands, including Good Supply, B! NGO, Solei, RIFF, and Broken Coast.
Is Aphria a buy right now?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 3 hold ratings and 2...
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share for the quarter, mi...
What price target have analysts set for APHA?
5 brokerages have issued twelve-month target prices for Aphria's shares. Their forecasts range from $18.00 to $26.00. On average, they expect Aphri...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $5.23M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF) , Canopy Growth (CGC) , Tilray (TLRY) , USANA H...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Grou...
What is Aphria's stock symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $15.38.
How much money does Aphria make?
Aphria has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63.21 million in net in...
Is Aphria a buy right now?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 3 hold ratings and 1...
What price target have analysts set for APHA?
4 analysts have issued 1-year price objectives for Aphria's shares. Their forecasts range from C$16.00 to C$28.00. On average, they anticipate Aphr...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $6.54M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Bausch Health Companies (BHC) , Valeant Pharmaceuticals International (VRX) , Evotec (EVT) ,...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB) , Cano...
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."
How do I buy shares of Aphria?
Shares of APHA and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadia...
How much money does Aphria make?
Aphria has a market capitalization of C$0.00 and generates C$611.06 million in revenue each year.
How many employees does Aphria have?
Aphria employs 1,200 workers across the globe.
About Aphria
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands.
Aphria (NASDAQ:APHA) Frequently Asked Questions
5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Aphria stock.
